Rare diseases
Investigational molecules
Locations
A study to evaluate the safety and effectiveness of BNT324 and BNT327 in patients with advanced lung cancer
PolandN1T-MC-MALO: A Master Protocol for a Randomized, Controlled, Clinical Trial of Multiple Pharmacologic Agents in Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease Who Are at Increased Risk of Developing Major Adverse Liver Outcomes (SYNERGY-Outcomes); N1T-MC-TZ01 Tirzepatide in participants with high-risk MASLD; N1T-MC-RT01 Retatrutide in participants with high-risk MASLD
PolandStudy of ublituximab compared to fingolimod for children and teenagers aged 10 to 17 years with relapsing multiple sclerosis
PolandPolandA study testing the safety and effectiveness of BP1.
PolandStudy of Trastuzumab Deruxtecan Versus Chemotherapy as Additional Treatment After Surgery for Patients with HER2-Positive Endometrial Cancer
PolandA study testing BNT326 and BNT327 with drug combination for safety and effectiveness in people with advanced non-small cell lung cancer
PolandA Study of Enlicitide for Safety and Effectiveness in Children and Adolescents with Heterozygous Familial Hypercholesterolemia
PolandA study of bleximenib combined with intensive chemotherapy for adults with newly diagnosed acute myeloid leukemia with specific genetic changes.
PolandA study comparing prasinezumab with placebo for people with early-stage Parkinson's disease
PolandStudy of STK-012 Alone and Combined with Chemotherapy in Patients with Advanced Non-Small Cell Lung Cancer
PolandTesting MK-2870 with pembrolizumab compared to pembrolizumab alone after surgery in patients with non-small cell lung cancer who did not respond fully to treatment
PolandTell us about your condition – we search every trial in Europe and connect you with the right site.
